Mislabeled insulin syringes manufactured by Covidien. Ltd. and sold by Wal-Mart and Sam's Club stores have been recalled, according to a report in the New York Times, "Insulin Syringes Are Recalled." The recall was announced by the Food and Drug Administration. The mislabeling could cause patients to receive 2.5 times the normal dose; approximately 471,000 syringes, which go by the brand name ReliOn, are said to affected.
« "Get Out of Jail" Free Cards For Corporations -- American Association for Justice Details Undermining of Family and Consumer Protections | Main | HIPAA Violated By Defense Counsel's Interviews of Plaintiff's Prior Treating Physicians »
November 07, 2008
Mislabeled Insulin Syringes Recalled
| | |
| | |
The comments to this entry are closed.
Categories
- AAJ
- America
- American Association for Justice
- arbitration
- attorneys fees
- bad faith insurance practices
- class action
- Clean Water Act
- consumer fraud
- consumer protection
- consumer safety
- corporate accountability
- criminal justice
- drugs
- equal pay
- evidence
- expert witness
- fair pay
- family safety
- FDA
- federal courts
- First Amendment
- Food and Drug Administration
- food safety
- Fourth Amendment
- free speech
- Hartford Life
- health insurance
- highway safety
- HIPAA
- hospitals
- insurance claims handling
- insurance coverage
- judicial campaign contributions
- judicial elections
- justice system
- lawsuit procedures
- lawyer advertising
- legal education
- legal malpractice
- medical insurance
- medical malpractice
- mine safety
- mining safety
- miscellaneous shenanigans
- nursing homes
- pay discrimination
- peanut butter
- personal injury
- predatory lending
- preemption
- product recall
- public safety
- search & seizure
- sentencing guidelines
- sex discrimination
- Sixth Circuit
- Supreme Court
- tort reform
- toxic substances
- unsafe products
- workplace safety
- wrongful death
Comments